Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kat's Naturals is a private U.S. wellness company that manufactures and sells hemp-derived cannabinoid products, primarily CBD formulations, through a direct-to-consumer and retail model. The company markets therapeutic and organic products including sublingual oils, edibles, topical creams, and pet-oriented formulations. Founded by Kat Merryfield, the business positions itself around natural health, herbalism, and premium cannabinoid wellness rather than prescription biopharma development. It appears to operate as a commercial-stage consumer health brand, not a clinical-stage drug developer, and there is no evidence of a traditional biotech pipeline with regulated therapeutic candidates in human clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kat's Naturals.